Lung Cancer

Lung Cancer News

 

Lung Cancer Perspectives

  • EGFR TKIs in Non-Asians With NSCLC: A New Treatment Paradigm EGFR TKIs in Non-Asians With NSCLC: A New Treatment Paradigm Firstline EGFR TKIs in Asians with mutation-positive NSCLC are known to improve outcomes. Dr. Maurie Markman reviews data on their use in Europeans and considers the impact on treatment protocols.
  • Implications of a New Target in NSCLC  Implications of a New Target in NSCLC The discovery of a new potential therapeutic target in non-small cell lung cancer prompts Dr. Howard (Jack) West to consider the clinical implications.
 

Journals

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.